Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
88.78M
Cash
35.63M
Avg Qtr Burn
-3.78M
Short % of Float
0.22%
Insider Ownership
22.57%
Institutional Own.
13.06%
Qtr Updated
06/30/24
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
MDNA55 (Bizaxofusp) Details Glioblastoma, Cancer | Phase 2b Update | |
MDNA11 (IL-2) Details Cancer, Cold tumors | Phase 1/2 Data readout |